capsaicin and telcagepant

capsaicin has been researched along with telcagepant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boyle, J; de Hoon, JN; de Lepeleire, I; Denney, WS; Depré, M; Hickey, L; Ho, TW; Kane, SA; Li, CC; Murphy, MG; Palcza, J; Sinclair, SR; Van der Schueren, BJ; Van Hecken, A; Vanmolkot, FH; Willson, KJ; Xiao, A; Xu, Y	1

Trials

1 trial(s) available for capsaicin and telcagepant

Article	Year
Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974). British journal of clinical pharmacology, 2010, Volume: 69, Issue:1 Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Capsaicin; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Forearm; Humans; Imidazoles; Laser-Doppler Flowmetry; Male; Middle Aged; Models, Biological; Regional Blood Flow; Skin; Vasodilator Agents; Young Adult	2010

Article

Year

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).

British journal of clinical pharmacology, 2010, Volume: 69, Issue:1

Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Capsaicin; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Forearm; Humans; Imidazoles; Laser-Doppler Flowmetry; Male; Middle Aged; Models, Biological; Regional Blood Flow; Skin; Vasodilator Agents; Young Adult

2010